Skip to main content

Table 2 Percentage of adherent patients per NOAC

From: NOACs replace VKA as preferred oral anticoagulant among new patients: a drug utilization study in 560 pharmacies in The Netherlands

 

Pct of patients

PDC* > =80

Nr of patients

Apixaban

92%

7094

Dabigatran

88%

11,782

Rivaroxaban

88%

13,975

Total

89%

32,851